Evidence map›Paper›PMID 27230014›Full record

ArticleCell cycle (Georgetown, Tex.)2016

Repriming by PrimPol is critical for DNA replication restart downstream of lesions and chain-terminating nucleosides.

Kaori Kobayashi, Thomas A Guilliam, Masataka Tsuda, Junpei Yamamoto, Laura J Bailey, Shigenori Iwai, Shunichi Takeda, Aidan J Doherty, Kouji Hirota

Open access · hybridAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 122 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Accurate DNA Synthesis Across 8-Oxoadenine by Human PrimPol.International journal of molecular sciences · 2025
    Article
  9. Article
  10. Article
  11. RAD18- and BRCA1-dependent pathways promote cellular tolerance to the nucleoside analog ganciclovir.Genes to cells : devoted to molecular & cellular mechanisms · 2024
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Kaori Kobayashia Department of Chemistry , Graduate School of Science and Engineering, Tokyo Metropolitan University , Hachioji-shi, Tokyo , Japan.
Thomas A Guilliamb Genome Damage and Stability Center, School of Life Sciences, University of Sussex , Brighton , UK.
Masataka Tsudac Department of Radiation Genetics , Graduate School of Medicine, Kyoto University, Yoshidakonoe , Sakyo-ku, Kyoto , Japan.
Junpei Yamamotod Division of Chemistry, Graduate School of Engineering Science, Osaka University , Toyonaka, Osaka , Japan.
Laura J Baileyb Genome Damage and Stability Center, School of Life Sciences, University of Sussex , Brighton , UK.
Shigenori Iwaid Division of Chemistry, Graduate School of Engineering Science, Osaka University , Toyonaka, Osaka , Japan.
Shunichi Takedac Department of Radiation Genetics , Graduate School of Medicine, Kyoto University, Yoshidakonoe , Sakyo-ku, Kyoto , Japan.
Aidan J Dohertyb Genome Damage and Stability Center, School of Life Sciences, University of Sussex , Brighton , UK.
Kouji Hirotaa Department of Chemistry , Graduate School of Science and Engineering, Tokyo Metropolitan University , Hachioji-shi, Tokyo , Japan.
University of Sussex · GBKyoto University · JPOsaka University · JPTokyo Metropolitan University · JP

Funding

Biotechnology and Biological Sciences Research Council BB/H019723/1
6 · The paper itself

Abstract

PrimPol is a DNA damage tolerance enzyme possessing both translesion synthesis (TLS) and primase activities. To uncover its potential role in TLS-mediated IgVλ hypermutation and define its interplay with other TLS polymerases, PrimPol(-/-) and PrimPol(-/-)/Polη(-/-)/Polζ (-/-) gene knockouts were generated in avian cells. Loss of PrimPol had no significant impact on the rate of hypermutation or the mutation spectrum of IgVλ. However, PrimPol(-/-) cells were sensitive to methylmethane sulfonate, suggesting that it may bypass abasic sites at the IgVλ segment by repriming DNA synthesis downstream of these sites. PrimPol(-/-) cells were also sensitive to cisplatin and hydroxyurea, indicating that it assists in maintaining / restarting replication at a variety of lesions. To accurately measure the relative contribution of the TLS and primase activities, we examined DNA damage sensitivity in PrimPol(-/-) cells complemented with polymerase or primase-deficient PrimPol. Polymerase-defective, but not primase-deficient, PrimPol suppresses the hypersensitivity of PrimPol(-/-) cells. This indicates that its primase, rather than TLS activity, is pivotal for DNA damage tolerance. Loss of TLS polymerases, Polη and Polζ has an additive effect on the sensitivity of PrimPol(-/-) cells. Moreover, we found that PrimPol and Polη-Polζ redundantly prevented cell death and facilitated unperturbed cell cycle progression. PrimPol(-/-) cells also exhibited increased sensitivity to a wide variety of chain-terminating nucleoside analogs (CTNAs). PrimPol could perform close-coupled repriming downstream of CTNAs and oxidative damage in vitro. Together, these results indicate that PrimPol's repriming activity plays a central role in reinitiating replication downstream from CTNAs and other specific DNA lesions.

Indexed as

DNA DamageDNA ReplicationAnimalsBiocatalysisCell LineCell SurvivalChickensCisplatinDNA-Directed DNA PolymeraseDNA PrimaseImmunoglobulin lambda-ChainsImmunoglobulin Variable RegionMethyl MethanesulfonateNucleosidesSomatic Hypermutation, ImmunoglobulinUltraviolet RaysCisplatinDNA-Directed DNA PolymeraseDNA polymerase zetaDNA PrimaseImmunoglobulin lambda-ChainsImmunoglobulin Variable RegionMethyl MethanesulfonateNucleosidesRad30 proteinY-Family DNA Polymeraseschain-terminating nucleoside analogs (CTNAs)DT40primase; primpol; polymerase; replication; repriming; restart

Identifiers

PMID27230014
PMCPMC4968974
OpenAlexW2408638299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.